Hematology/Oncology

Top Story

Roswell Park Cancer Institute names department chairman

April 23, 2017

John Krolewski , MD, PhD, has been named chair of the department of cancer genetics and genomics at Roswell Park Cancer Institute.

Krolewski — who served as interim chair of the department since March 2016 — also will serve as co-leader of the cancer center support grant genetics and genomics program, and he will hold the John and Santa Palisano endowed chair of cancer genetics and genomics.

Association of Community Cancer Centers names 2017-2018 president

April 22, 2017
Mark S. Soberman , MD, MBA, FACS, has been elected president of the Association of Community Cancer Centers for the 2017-2018 term. Soberman —…
Meeting News

Sorafenib, selective internal radiation yield similar survival in HCC

April 22, 2017
AMSTERDAM — Selective internal radiation therapy failed to best Nexavar in overall survival but did yield improvements in other parameters, including quality of…
In the Journals Plus

Women considering double mastectomies satisfied with surgery choices

April 21, 2017

Biosimilars to rituximab, etanercept recommended for approval in Europe

April 21, 2017
The Committee for Medicinal Products for Human Use has recommended approval of biosimilars by Sandoz for rituximab and etanercept for the same indications as the…
More News Headlines »
CME CNE CPE

Individualized Prophylaxis in Hemophilia

Support for this activity has been made possible through an educational grant from Bayer HealthCare Pharmaceuticals

This program will provide education for hematologists, nurses, pharmacists, and other healthcare providers involved in…
More »
Video
Meeting News

VIDEO: Speaker offers updates in cutaneous squamous cell carcinoma

April 16, 2017
More »
Featured
American Association for Cancer Research Annual Meeting

American Association for Cancer Research Annual Meeting

CME

What's Hot in Melanoma? Highlights from the HemOnc Today Melanoma and Cutaneous Malignancies 2017 Meeting

This activity is supported by an educational grant from Merck & Co, Inc.

The development and integration of targeted therapies, as well as immunotherapies, into clinical strategies for the…
More »
Current Issues
View the Current Issue
HemOnc Today
Advertisement
Advertisement